变量 | 1年总生存率 | 5年总生存率 | ||
HR (95%CI) | p值 | HR (95%CI) | p值 | |
扩展标准供体(ECD)* | 1.01 (0.86~1.19) | 0.53 | 1.11 (1.00~1.24) | 0.04 |
受体年龄 ≥ 65岁 | 1.20 (1.00~1.45) | 0.05 | 1.34 (1.18~1.52) | <0.001 |
受体BMI,kg/m2 | ||||
18.5~30 | Ref | Ref | Ref | Ref |
<18.5 | 1.36 (0.98~1.89) | 0.06 | 1.25 (1.01~1.54) | 0.04 |
25~30 | 1.30 (1.07~1.58) | 0.008 | 1.14 (1.00~1.29) | 0.05 |
≥30 | 1.60 (1.28~2.00) | <0.001 | 1.45 (1.26~1.68) | <0.001 |
受体性别(女性) | 0.88 (0.74~1.05) | 0.17 | 0.92 (0.82~1.03) | 0.13 |
受体种族 | ||||
白人 | Ref | Ref | Ref | Ref |
黑人 | 1.01 (0.79~1.30) | 0.93 | 1.01 (0.85~1.19) | 0.95 |
西班牙裔人 | 0.81 (0.62~1.05) | 0.11 | 0.93 (0.78~1.11) | 0.42 |
其他 | 0.77 (0.50~1.18) | 0.23 | 0.70 (0.51~0.96) | 0.03 |
受体糖尿病 | 1.05 (0.88~1.25) | 0.59 | 1.04 (0.92~1.17) | 0.55 |
LAS受体诊断组 |
|
|
|
|
阻塞性肺病 | Ref | Ref | Ref | Ref |
肺动脉高压 | 1.44 (0.84~2.49) | 0.19 | 1.40 (0.95~2.07) | 0.09 |
囊性纤维化或免疫性肺病 | 0.94 (0.61~1.45) | 0.78 | 1.02 (0.77~1.36) | 0.87 |
限制性肺病 | 0.75 (0.53~1.08) | 0.13 | 0.83 (0.65~1.06) | 0.13 |
单肺移植 | 1.59 (1.30~1.94) | <0.001 | 1.47 (1.29~1.69) | <0.001 |
供体BMI,kg/m2 | ||||
18.5~30 | Ref | Ref | Ref | Ref |
<18.5 | 0.94 (0.62~1.44) | 0.79 | 0.85 (0.64~1.14) | 0.27 |
25~30 | 0.9 (0.75~1.07) | 0.24 | 0.95 (0.84~1.07) | 0.38 |
≥30 | 0.83 (0.67~1.02) | 0.07 | 0.90 (0.78~1.03) | 0.11 |
供体性别(女性) | 1.12 (0.94~1.32) | 0.20 | 1.09 (0.98~1.22) | 0.13 |
供体种族 | ||||
白人 | Ref | Ref | Ref | Ref |
黑人 | 1.31 (1.08~1.60) | 0.006 | 1.25 (1.09~1.43) | 0.001 |
西班牙裔人 | 1.07 (0.85~1.33) | 0.57 | 0.99 (0.85~1.15) | 0.86 |
其他 | 1.06 (0.73~1.56) | 0.75 | 1.13 (0.88~1.45) | 0.35 |
供体死亡原因 | ||||
缺氧 | Ref | Ref | Ref | Ref |
脑血管疾病/中风 | 1.16 (0.94~1.41) | 0.16 | 1.10 (0.96~1.26) | 0.19 |
脑部创伤 | 0.89 (0.72~1.10) | 0.29 | 0.97 (0.84~1.11) | 0.65 |
中枢神经系统肿瘤 | 0.60 (0.19~1.89) | 0.39 | 0.81 (0.42~1.57) | 0.53 |
其他 | 0.75 (0.43~1.32) | 0.32 | 1..00 (0.72~1.37) | 0.98 |
离体肺灌注(EVLP)的使用 | 1.08 (0.62~1.88) | 0.79 | 1.25 (0.83~1.90) | 0.29 |